AI-fueled Isomorphic bags $2.1B, the second largest biotech round ever (May 13, 2026) by Tristan Manalac Isomorphic Labs, which hasn’t yet disclosed a molecule or reached the clinic, breaks the recent trend of investors putting their money behind more mature and de-risked assets. Alphabet’s AI-forward biotech Isomorphic Labs has brought in $2.1 billion, clocking what analysts say is “the second